Advertisement
UK markets close in 6 hours 8 minutes
  • FTSE 100

    8,088.16
    +47.78 (+0.59%)
     
  • FTSE 250

    19,724.96
    +5.59 (+0.03%)
     
  • AIM

    755.01
    +0.32 (+0.04%)
     
  • GBP/EUR

    1.1672
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.2518
    +0.0055 (+0.44%)
     
  • Bitcoin GBP

    51,146.74
    -1,923.54 (-3.62%)
     
  • CMC Crypto 200

    1,363.00
    -19.57 (-1.42%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.87
    +0.06 (+0.07%)
     
  • GOLD FUTURES

    2,339.10
    +0.70 (+0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,987.44
    -101.26 (-0.56%)
     
  • CAC 40

    8,055.58
    -36.28 (-0.45%)
     

Did You Miss Terveystalo Oyj's (HEL:TTALO) 48% Share Price Gain?

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). For example, the Terveystalo Oyj (HEL:TTALO) share price is up 48% in the last year, clearly besting the market return of around 13% (not including dividends). That's a solid performance by our standards! Note that businesses generally develop over the long term, so the returns over the last year might not reflect a long term trend.

Check out our latest analysis for Terveystalo Oyj

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

ADVERTISEMENT

Over the last twelve months, Terveystalo Oyj actually shrank its EPS by 28%.

This means it's unlikely the market is judging the company based on earnings growth. Indeed, when EPS is declining but the share price is up, it often means the market is considering other factors.

We doubt the modest 1.6% dividend yield is doing much to support the share price. However the year on year revenue growth of 30% would help. We do see some companies suppress earnings in order to accelerate revenue growth.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

HLSE:TTALO Income Statement, February 12th 2020
HLSE:TTALO Income Statement, February 12th 2020

We know that Terveystalo Oyj has improved its bottom line over the last three years, but what does the future have in store? You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Terveystalo Oyj, it has a TSR of 52% for the last year. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!

A Different Perspective

It's nice to see that Terveystalo Oyj shareholders have gained 52% over the last year , including dividends . A substantial portion of that gain has come in the last three months, with the stock up 15% in that time. This suggests the company is continuing to win over new investors. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Terveystalo Oyj has 3 warning signs we think you should be aware of.

We will like Terveystalo Oyj better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on FI exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.